Mania: Diagnosis and Treatment Recommendations

  title={Mania: Diagnosis and Treatment Recommendations},
  author={Gin S. Malhi and Michelle Tanious and Michael Berk},
  journal={Current Psychiatry Reports},
This article provides recommendations for the diagnosis and treatment of mania, which characterizes bipolar I disorder (BD I). Failure to detect mania leads to misdiagnosis and suboptimal treatment. To diagnose mania, clinicians should include a detailed mood history within their assessment of patients presenting with depression, agitation, psychosis or insomnia. With regards to treatment, by synthesizing the findings from recent treatment guidelines, and reviewing relevant literature, this… 

Prolonged mania in a case of bipolar affective disorder.

  • Ather Muneer
  • Psychology, Medicine
    JPMA. The Journal of the Pakistan Medical Association
  • 2014
In a case where manic symptoms are showing resistance, an evidence-based pharmacotherapuetic approach by the treating physician is essential and the provision of psychological and social support to the patient is vital in conjunction with biological measures for optimal management.

Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?

The available evidence indicates that bipolar disorder patients should be treated primarily with lithium, combined in some cases with antipsychotics especially in acute treatments, and sometimes, because of intolerance or inefficacy of lithium, with anticonvulsants.

The use of benzodiazepines in bipolar disorders

Although benzodiazepines have many benefits for patients with bipolar disorders, their use must be very cautious, because of the associated risk of misuse and other possible consequences, especially in some particular clinical situations.

Bipolar disorder

Efficacy and Safety of Asenapine Versus Olanzapine in Combination With Divalproex for Acute Mania: A Randomized Controlled Trial.

It is found that asenapine was an effective and well-tolerated atypical antipsychotic alternative to olanzapine in combination with divalproex for the short-term management of acute mania.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

The Mood Disorder CPG is the first Clinical Practice Guideline to address both depressive and bipolar disorders and provides up-to-date recommendations and guidance within an evidence-based framework, supplemented by expert clinical consensus.

Bipolar Affective Disorder

Manic-depressive disorder--more contemporarily identified as bipolar disorder (BD)--is a chronic and complex disorder of mood that is characterized by a combination of manic, hypomanic, and depressive episodes, with subsyndromal symptoms extant in between the mood episodes.



New treatment guidelines for acute bipolar mania: a critical review.

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry

A systematic review of the available data concerning the efficacy of medication treatment of bipolar disorder (BP) suggests that lithium, first and second generation antipsychotics and valproate and carbamazepine are efficacious in the treatment of acute mania.

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.

The guidelines suggest that although pharmacotherapy forms the cornerstone of management, utilization of adjunctive psychosocial treatments and incorporation of chronic disease management model involving a healthcare team are required in providing optimal management for patients with bipolar disorder.

Prevalence of mixed mania using 3 definitions.

Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.

Asenapine monotherapy is a further option for the management of manic and/or mixed symptoms in patients with bipolar I disorder and may be of particular value for patients who are at high risk for metabolic abnormalities.

Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.

The evidence from treatment trials favours the use of lithium and lamotrigine as first-line treatment in preference to valproate, and indicates that, for acute episodes, quetiapine and olanzapine have perhaps achieved equivalence at least in terms of efficacy.

Efficacy of psychoeducational approaches on bipolar disorders: a review of the literature.

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

  • G. Goodwin
  • Psychology, Medicine
    Journal of psychopharmacology
  • 2009
The British Association for Psychopharmacology guidelines specify the scope and target of treatment for bipolar disorder, and are presented as recommendations to aid clinical decision making for practitioners: they may also serve as a source of information for patients and carers.

Bipolar pathophysiology and development of improved treatments

Lithium specificity in bipolar illness: a classic agent for the classic disorder.

It is demonstrated that lithium possesses significant clinical and therapeutic efficacy that is very individual and thus remains the treatment of choice for bipolar disorder when used specifically in select patients and its phenotypic specificity of action.